Corrigendum to “Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy” Exp Neurol. 2012 April; 234(2): 405–416 (Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy (2012) 234(2) (405–416), (S001448861200009X), (10.1016/j.expneurol.2012.01.008))

Ubhi K, Inglis C, Mante M, Patrick C, Adame A, Spencer B, Rockenstein E, May VEL, Winkler J, Masliah E (2024)


Publication Type: Journal article, Erratum

Publication year: 2024

Journal

Article Number: 114873

DOI: 10.1016/j.expneurol.2024.114873

Abstract

The authors regret that during the process of assembling the panels for Fig. 4 and error occurred where the incorrect panel was used to represent the the non transgenic saline PCNA condition in Fig. 4F. The corrected Fig. 4 including panel 4F is provided below. We apologize for any inconvenience caused, and have confirmed that the conclusions were not affected.[Formula presented]

Authors with CRIS profile

How to cite

APA:

Ubhi, K., Inglis, C., Mante, M., Patrick, C., Adame, A., Spencer, B.,... Masliah, E. (2024). Corrigendum to “Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy” Exp Neurol. 2012 April; 234(2): 405–416 (Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy (2012) 234(2) (405–416), (S001448861200009X), (10.1016/j.expneurol.2012.01.008)). Experimental Neurology. https://doi.org/10.1016/j.expneurol.2024.114873

MLA:

Ubhi, Kiren, et al. "Corrigendum to “Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy” Exp Neurol. 2012 April; 234(2): 405–416 (Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy (2012) 234(2) (405–416), (S001448861200009X), (10.1016/j.expneurol.2012.01.008))." Experimental Neurology (2024).

BibTeX: Download